NVO Latest Headlines

Novo Nordisk’s CagriSema Trial Puts Next-Generation Obesity Strategy in Focus

at www.tipranks.com (Fri, 29-May 12:34 PM)

Jefferies Reaffirms Their Hold Rating on Novo Nordisk (0QIU)

at www.tipranks.com (Fri, 29-May 11:35 AM)

France to become first EU nation to cover weight-loss meds

at seekingalpha.com (Thu, 28-May 10:43 AM)

Eli Lilly Stock (LLY) Jumps 5% as CVS Health Covers Its Weight-Loss Drugs

at www.tipranks.com (Thu, 28-May 10:31 AM)

Deutsche Bank Sticks to Its Hold Rating for Novo Nordisk (0QIU)

at www.tipranks.com (Thu, 28-May 7:57 AM)

CVS Health reintroduces coverage for Lilly’s Zepbound

at seekingalpha.com (Thu, 28-May 7:35 AM)

Eli Lilly Stock (LLY) Gets a Price Target Boost as Weight-Loss Drug Sales Accelerate

at www.tipranks.com (Wed, 27-May 11:58 AM)

Novo Nordisk Details Progress in DKK 15 Billion Share Buyback Programme

at www.tipranks.com (Wed, 27-May 6:30 AM)

Kinnevik names Helena Saxon as new CEO

at seekingalpha.com (Mon, 25-May 4:23 AM)

SA Asks: What are the most attractive biotech stocks right now?

at seekingalpha.com (Sun, 24-May 4:13 PM)

Novo Nordisk Expands Its GLP-1 Leadership: New Phase 3 Data Points to Long-Term Growth Beyond Diabetes

Market Chameleon (Thu, 7-May 9:46 AM)

FDA Approves Novo Nordisk's Wegovy HD: New Injection Sets Highest Weight Loss Benchmark in STEP UP Trial

Market Chameleon (Fri, 20-Mar 11:00 AM)

FDA Approves Novo Nordisk’s Wegovy HD with Record Weight Loss Efficacy—STEP UP Trial Reveals 21% Average Reduction

Market Chameleon (Fri, 20-Mar 7:07 AM)